Biomaterial Database

The impact of clinical trials on clinical practice. 1989

C D Furberg

Center for Prevention Research and Biometry, Bowman Gray School of Medicine, Winston-Salem, N.C.

UI	MeSH Term	Description	Entries
D008389	Marketing of Health Services	Application of marketing principles and techniques to maximize the use of health care resources.	Health Services Marketing,Marketing Services, Health,Marketing, Health Services,Services, Health Marketing,Health Marketing Service,Health Marketing Services,Marketing Service, Health
D010820	Physicians	Individuals licensed to practice medicine.	Physician
D002986	Clinical Trials as Topic	Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.	Clinical Trial as Topic
D004358	Drug Therapy	The use of DRUGS to treat a DISEASE or its symptoms. One example is the use of ANTINEOPLASTIC AGENTS to treat CANCER.	Chemotherapy,Pharmacotherapy,Therapy, Drug,Chemotherapies,Drug Therapies,Pharmacotherapies,Therapies, Drug
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000960	Hypolipidemic Agents	Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS.	Antihyperlipidemic,Antilipemic,Antilipemic Agents,Antilipemic Drug,Hypolipidemic Agent,Hypolipidemic Drug,Antihyperlipemics,Antihyperlipidemics,Antilipemic Drugs,Antilipemics,Hypolipidemic Drugs,Agent, Hypolipidemic,Agents, Antilipemic,Agents, Hypolipidemic,Drug, Antilipemic,Drug, Hypolipidemic,Drugs, Antilipemic,Drugs, Hypolipidemic

Related Publications

C D Furberg

The impact of clinical practice guidelines and clinical trials on treatment decisions.

December 2002, Surgical oncology,

C D Furberg

Commentary: impact of EVAR and DREAM trials on clinical practice.

August 2007, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists,

C D Furberg

Secondary prevention of myocardial infarction: impact of clinical trials on clinical practice.

January 1995, European journal of clinical pharmacology,

C D Furberg

Upcoming TAVI trials: rationale, design and impact on clinical practice.

September 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology,

C D Furberg

Clinical trials in hypertension: an uncertain impact on physician practice.

March 2000, The Mount Sinai journal of medicine, New York,

C D Furberg

Mechanisms of the placebo response and their impact on clinical trials and clinical practice.

March 2005, Pain,

C D Furberg

[The impact of clinical trials in arterial hypertension in clinical practice].

July 1997, Cardiologia (Rome, Italy),

C D Furberg

Impact of randomized clinical trials on clinical practice regarding treatment of lung cancer.

May 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,